|
Market Cap (4-Jul) $3,153,122 (199th) |
Close (30-Jun) $0.091 |
Volume (30-Jun) 50,159,971 |
Shortsold (19-Jun) 392,315,164 (5.25%) (41st) |
|
52w High $2.75 |
52w Low $0.340 |
P/E - |
EPS -0.6 |
IMU released this announcement to the ASX on 15 November 2022, 10:15. The announcement is not marked as price sensitive, and is 31 page(s) in length and 4.19MB in size.
You can view all announcements from IMU and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMU was 4.085% short sold according to ASIC data. It was ranked the 62nd most shorted stock on the ASX. It is now ranked as the 41st most shorted stock on the ASX with 5.254% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMU | |
|---|---|
| Change of Director's Interest Notice | 30 June 2023, 16:33 |
| HER-Vaxx induced antibodies correlated with tumour reduction | 30 June 2023, 8:40 |
| Imugene PD1-Vaxx patent extended to 2040 | 29 June 2023, 8:39 |
| Imugene Investor Presentation | 15 November 2022, 10:15 |
| Imugene onCARlytics with Estrella ARTEMIS T Cells SITC | 14 November 2022, 9:41 |
| Application for quotation of securities - IMU | 11 November 2022, 15:25 |
| Dose escalates In Phase I Clinical Trial of New Oncolytic Vi | 11 November 2022, 11:04 |
You must be logged in to post a reply.
Imugene 